Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NovoSeven for Preventing Early Hematoma Growth in Acute ICH
NCT01563445Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Nov 2001
- Primary completion
- Mar 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of coagulation factor VIIa in intracerebral hemorrhage (ICH), sponsored by Novo Nordisk. Started Nov 2001; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT01563445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01563445.